This investigative report by Mina Kimes offers insights into Johnson and Johnson's quality control breakdowns, Why J&J's headache won't go away. This appears to be the same article published in Fortune magazine's September 6, 2010 issue.
QCU written procedures, lab controls top 483 citations in FY 2009.: An article from: Validation Times
Return Home: http://drughealth.blogspot.com/
GMP Posters
The Health, Drug, Prescription, and GMP Supersite Gift Store
Return to Mobile Home: http://drughealth.mofuse.mobi/
Monday, September 27, 2010
Johnson and Johnson GMP Headache - Insights
Add Post To: |
Digg|
Technorati|
del.icio.us|
Stumbleupon|
Reddit|
BlinkList|
Furl|
Spurl|
Yahoo|
Simpy
Tuesday, September 21, 2010
Mesothelioma Awareness Day 2010
All supporters, volunteers and patients affected by the asbestos-related cancer mesothelioma will help recognize Mesothelioma Awareness Day this Sunday on September 26, 2010. To learn more about this awareness day, go to the Foundation's webpage, Mesothelioma Awareness Day.
Return Home: http://drughealth.blogspot.com/
GMP Posters
The Health, Drug, Prescription, and GMP Supersite Gift Store
Return to Mobile Home: http://drughealth.mofuse.mobi/
Related articles by Zemanta
- 10 Choices In Treating Mesothelioma (healthlifestyleforever.com)
Labels:
asbestos,
awareness,
cancer,
day,
health,
marf,
mesothelioma,
Mesothelioma Applied Research Foundation
Add Post To: |
Digg|
Technorati|
del.icio.us|
Stumbleupon|
Reddit|
BlinkList|
Furl|
Spurl|
Yahoo|
Simpy
Monday, September 20, 2010
FDA Guidance - Impact Resistant Lenses - Q and A
Guidance for Industry and FDA Staff - Impact-Resistant Lenses: Questions and Answers represents the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. As you read through the guidance, you'll find quite a number of useful hyperlinks to additional information and references.
Eyeglasses and sunglasses (eyewear) that are intended to affect the structure or function of the body or intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, are devices within the meaning of section 201(h) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 321(h)). These devices are subject to applicable device regulations under Title 21, Code of Federal Regulations. Impact-resistant lenses reduce the number of eye injuries from eyeglasses and sunglasses. Glass lenses, plastic lenses, or laminated glass lenses can be made impact resistant by any method. However, lenses generally must be capable of withstanding the impact test described in 21 CFR 801.410. This guidance answers questions for manufacturers, importers, and testing laboratories on such topics as test procedures, lens testing apparatus, record maintenance, and exemptions to testing.
This guidance is a revision of “Impact-Resistant Lenses: Questions and Answers (FDA 87-4002),” issued September 1987. This guidance updates answers to questions that industry and consumers frequently ask FDA about impact-resistant lenses and FDA regulation of eyewear. The revision reflects the exemption of sunglasses from the Premarket Notification (510(k)) requirement effective February 19, 1998 (21 CFR 886.5850(b)). The revised document also includes a more detailed discussion about lens blanks, semi-finished, finished, and plano lenses, as well as import procedures. The terms "eyeglasses" and "spectacles" are used interchangeably in this document.
Eyewear products regulated by FDA are commonplace in the daily lives of the vast majority of the general public. FDA believes that impact-resistant lenses are an essential component of the safe design of these devices. The use of impact-resistant lenses in eyeglasses and sunglasses is addressed in 21 CFR 801.410.
For more information on this topic, contact the Division of Small Manufacturers, International, and Consumer Assistance (DSMICA) by phone at 1-800-638-2041, by fax at 301-847-8149, by e-mail at dsmica@fda.hhs.gov, or write to the following address:
U.S. Food and Drug Administration
Center for Devices and Radiological Health
Office of Communication, Education and Radiation Programs
Division of Small Manufacturers, International, and Consumer Assistance
10903 New Hampshire Ave.
WO66-4613
Silver Spring, Maryland 20993
Return Home: http://drughealth.blogspot.com/
GMP Posters
The Health, Drug, Prescription, and GMP Supersite Gift Store
Return to Mobile Home: http://drughealth.mofuse.mobi/
AUTHENTIC DOLCE&GABBANA SUNGLASSES D&G 8039 TORTOISE 502/73
Eyeglasses and sunglasses (eyewear) that are intended to affect the structure or function of the body or intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, are devices within the meaning of section 201(h) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 321(h)). These devices are subject to applicable device regulations under Title 21, Code of Federal Regulations. Impact-resistant lenses reduce the number of eye injuries from eyeglasses and sunglasses. Glass lenses, plastic lenses, or laminated glass lenses can be made impact resistant by any method. However, lenses generally must be capable of withstanding the impact test described in 21 CFR 801.410. This guidance answers questions for manufacturers, importers, and testing laboratories on such topics as test procedures, lens testing apparatus, record maintenance, and exemptions to testing.
This guidance is a revision of “Impact-Resistant Lenses: Questions and Answers (FDA 87-4002),” issued September 1987. This guidance updates answers to questions that industry and consumers frequently ask FDA about impact-resistant lenses and FDA regulation of eyewear. The revision reflects the exemption of sunglasses from the Premarket Notification (510(k)) requirement effective February 19, 1998 (21 CFR 886.5850(b)). The revised document also includes a more detailed discussion about lens blanks, semi-finished, finished, and plano lenses, as well as import procedures. The terms "eyeglasses" and "spectacles" are used interchangeably in this document.
Eyewear products regulated by FDA are commonplace in the daily lives of the vast majority of the general public. FDA believes that impact-resistant lenses are an essential component of the safe design of these devices. The use of impact-resistant lenses in eyeglasses and sunglasses is addressed in 21 CFR 801.410.
For more information on this topic, contact the Division of Small Manufacturers, International, and Consumer Assistance (DSMICA) by phone at 1-800-638-2041, by fax at 301-847-8149, by e-mail at dsmica@fda.hhs.gov, or write to the following address:
U.S. Food and Drug Administration
Center for Devices and Radiological Health
Office of Communication, Education and Radiation Programs
Division of Small Manufacturers, International, and Consumer Assistance
10903 New Hampshire Ave.
WO66-4613
Silver Spring, Maryland 20993
Return Home: http://drughealth.blogspot.com/
GMP Posters
The Health, Drug, Prescription, and GMP Supersite Gift Store
Return to Mobile Home: http://drughealth.mofuse.mobi/
AUTHENTIC DOLCE&GABBANA SUNGLASSES D&G 8039 TORTOISE 502/73
Related articles by Zemanta
- Johnson & Johnson recalls contact lenses overseas (usatoday.com)
- Hot Sunglass Trends in Summer (shoesaccessories.suite101.com)
- An overall introduction of sunglasses (fitfiend.com)
- Esquire: The 10 Best Sunglasses of 2010 (esquire.com)
- Dial A for adaptive eyeglasses for the masses (news.cnet.com)
Labels:
21 cfr,
device,
fda,
FDC,
glasses,
guidance,
health,
impact,
industry,
lenses,
medical,
regulated,
resistance,
sunglasses,
testing
Add Post To: |
Digg|
Technorati|
del.icio.us|
Stumbleupon|
Reddit|
BlinkList|
Furl|
Spurl|
Yahoo|
Simpy
Monday, September 13, 2010
Electronic Orange Book Online
The FDA offers an electronic (online) version of the Orange Book, also known as Approved Drug Products with Therapeutic Equivalence Evaluations.
Here are the important links to the electronic Orange Book:
Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
Orange Book: Search by Active Ingredient
Orange Book: Search by Proprietary Name
Orange Book: Publications - PDF versions of the annual edition and cumulative supplements
Return Home: http://drughealth.blogspot.com/
GMP Posters
The Health, Drug, Prescription, and GMP Supersite Gift Store
Return to Mobile Home: http://drughealth.mofuse.mobi/
Here are the important links to the electronic Orange Book:
Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
Orange Book: Search by Active Ingredient
Orange Book: Search by Proprietary Name
Orange Book: Publications - PDF versions of the annual edition and cumulative supplements
Return Home: http://drughealth.blogspot.com/
GMP Posters
The Health, Drug, Prescription, and GMP Supersite Gift Store
Return to Mobile Home: http://drughealth.mofuse.mobi/
Labels:
active,
book,
drug,
electronic,
fda,
free,
health,
information,
ingredient,
name,
online,
orange,
orange book,
otc,
prescription,
proprietary,
reference,
resource
Add Post To: |
Digg|
Technorati|
del.icio.us|
Stumbleupon|
Reddit|
BlinkList|
Furl|
Spurl|
Yahoo|
Simpy
Monday, September 6, 2010
FDA Form 483 Search Tool
FDAzilla offers a specialized search tool that makes it possible to search for Form 483 observations issued by the FDA.
One possible use of the search tool is to get a listing of Form 483s issued to companies in a particular country, for example, the search results of form 483 observations issued to companies in India. Just alter your search keywords to view different results.
Related reading: Compliance Remediation for Pharmaceutical Manufacturing: A Project Management Guide for Re-establishing FDA Compliance
You might also be interested in:
An extensive library of 483 citation summaries from the FDA. Match the case with the corresponding 21 CFR 211 reference. Used as a classroom training tool or for self-study, this training aid challenges the student to identify and justify the 21 CFR 211 reference that supports the 483 citation.Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
GMP Posters by SkillsPlus Intl Inc.
SkillsPlus Intl Inc. - GMP Compliance Training Experts
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store
Related articles by Zemanta
Add Post To: |
Digg|
Technorati|
del.icio.us|
Stumbleupon|
Reddit|
BlinkList|
Furl|
Spurl|
Yahoo|
Simpy
Saturday, September 4, 2010
FDA - Safe Drug Use After Natural Disasters
Floods, fires, earthquakes, hurricanes, oh my. The FDA provides recommendations on Safe Drug Use After a Natural Disaster. Here's what they cover:
Drugs Exposed to Excessive Heat, such as Fire
Drugs Exposed to Unsafe Water
Drugs that Need Refrigeration
For more information:
FDA - Natural Disaster Response
FDA - Hurricanes: Health and Safety
Return Home: http://drughealth.blogspot.com/
GMP Posters
The Health, Drug, Prescription, and GMP Supersite Gift Store
Return to Mobile Home: http://drughealth.mofuse.mobi/
If you want to learn more: Emergency Preparedness The Right Way
Drugs Exposed to Excessive Heat, such as Fire
Drugs Exposed to Unsafe Water
Drugs that Need Refrigeration
For more information:
FDA - Natural Disaster Response
FDA - Hurricanes: Health and Safety
Return Home: http://drughealth.blogspot.com/
GMP Posters
The Health, Drug, Prescription, and GMP Supersite Gift Store
Return to Mobile Home: http://drughealth.mofuse.mobi/
If you want to learn more: Emergency Preparedness The Right Way
Related articles by Zemanta
- Natural Disasters: 7 Record-Breaking Catastrophes (PHOTOS) (huffingtonpost.com)
- New Zealand Earthquake Takes 2010 Over the Top (pamil-visions.net)
Labels:
disaster,
drug,
earthquake,
fda,
fire,
flood,
handling,
health,
hurricane,
medication,
medicine,
natural,
planning,
preparedness,
prescription,
safety,
storage,
use
Add Post To: |
Digg|
Technorati|
del.icio.us|
Stumbleupon|
Reddit|
BlinkList|
Furl|
Spurl|
Yahoo|
Simpy
Subscribe to:
Posts (Atom)
Top Content And Other Useful Links
- GMP Posters - for Training & Quality
- FDA 483 Inspectional Observations - learn from these examples
- WHO Basic GMP Training Modules (free)
- FDA Orange Book - Online (free)
- GXP Acronym Gifts (gift, award, reward & recognition, giveaway)
- The Health, Drug, Prescription, and GMP Supersite Gift Store (gifts, awards, rewards & recognition, giveaways, mugs, bags, mousepads, coasters, posters, and more!)
Even More Resources, Books, & Things (many from Amazon.com)
FDA, GMPs, QSR, GCP, GLP, GXP:
21 CFR Parts 210 and 211: Drug Industry GMP's
Compact Regs Parts 807, 812, and 814: CFR 21 Parts 807, 812, and 814 Medical Device Approval (10 Pack)
The FDA and Worldwide Quality System Requirements Guidebook for Medical Devices
Compact Regs Part 11: CFR 21 Part 11 Electronic Records; Electronic Signatures (10 Pack)
How to Fail an Fda Quality Audit: A Look at Some of the Causes of Failure to Comply With Fda Quality Regulations
Pharmaceutical Master Validation Plan: The Ultimate Guide to FDA, GMP, and GLP Compliance
How to Develop and Manage Qualification Protocols for FDA Compliance
Agent GXP FDA Part 11 Guidebook: The FDA Regulations on Part 11, Electronic Records and Electronic Signatures, For Pharmaceutical, Medical Device, Food, ... Trials and GCP (Good Clinical Practices)
Development of Fda-Regulated Medical Products: Prescription Drugs, Biologics, and Medical Devices
FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics
Design and Analysis of Clinical Trials: Concepts and Methodologies (Wiley Series in Probability and Statistics)
Clinical Studies Management: A Practical Guide to Success
Analytical Chemistry in a GMP Environment: A Practical Guide
Process Validation in Manufacturing of Biopharmaceuticals: Guidelines, Current Practices, and Industrial Case Studies (Biotechnology and Bioprocessing Series)
Pharmaceutical Equipment Validation: The Ultimate Qualification Guidebook
Preclinical Drug Development (Drugs and the Pharmaceutical Sciences)
Group Sequential Methods: Applications to Clinical Trials (Chapman & Hall/Crc Interdisciplinary Statistics Series)
Validation Standard Operating Procedures: A Step by Step Guide for Achieving Compliance in the Pharmaceutical, Medical Device, and Biotech Industries, Second Edition
Pharmaceutical Stress Testing: Predicting Drug Degradation (Drugs and the Pharmaceutical Sciences)
Cleaning Validation: A Practical Approach
Validated Cleaning Technologies for Pharmaceutical Manufacturing
Risk-Based Compliance Handbook
Microbiology in Pharmaceutical Manufacturing, Second Edition, Revised and Expanded, Volume I (1)
Microbiology in Pharmaceutical Manufacturing, Second Edition, Revised and Expanded (Volume 2)
Bioprocess Validation: The Present and Future
Laboratory Validation: A Practitioner's Guide
Quality Assurance Workbook for Pharmaceutical Manufacturers
Risk-based Software Validation: Ten Easy Steps
ISO 13485 and FDA QSR Internal Audit Checklist
ISO 13485:2003 & FDA QSR (21 CFR 820) Quality Manual, 34 Procedures and Forms
Training Resources:
1001 Ways to Reward Employees
Planning Programs for Adult Learners: A Practical Guide for Educators, Trainers, and Staff Developers, 2nd Edition
50 Creative Training Openers and Energizers
Personalized M&M Candies
Oriental Trading Co - Training toys and supplies
GMP Training Gifts & Giveaways
GMP Training & Quality Posters
21 CFR Parts 210 and 211: Drug Industry GMP's
Training Resources:
1001 Ways to Reward Employees






